Skip to content

Clinical trials

Observational Hypertension, Pulmonary trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Observational Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20132
20141
20152
20173
20183
20191
20203
20212
20221
20233
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Completed9
Unknown status8
Active, not recruiting2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Pulmonary Vascular Disease Research Group5
Chinese Academy of Medical Sciences, Fuwai Hospital3
China National Center for Cardiovascular Diseases2
RenJi Hospital2
Wei Huang2
Actelion1
Association for Pediatric Pulmonary Hypertension1
China-Japan Friendship Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
First Affiliated Hospital of Chongqing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary34
Pulmonary Arterial Hypertension8
Disease5
Heart Failure4
Bronchiectasis2
Pulmonary Disease, Chronic Obstructive2
Death1
Heart Septal Defects, Atrial1
Hypoxia1
Idiopathic Pulmonary Fibrosis1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.